Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanxi Aoxun Medicine is a pharmaceutical company based in Taiyuan, China, that focuses on the development, manufacturing, and commercialization of chemical drugs and active pharmaceutical ingredients (APIs). The company's product portfolio spans several therapeutic areas, including respiratory, anti-infective, and cardiovascular medicine, with a strong emphasis on high-quality generic formulations. Operating under strict GMP standards, Shanxi Aoxun produces widely used medications such as ambroxol hydrochloride and various macrolide antibiotics. The firm serves as a significant regional manufacturer in the Shanxi province, supplying both finished dosages and raw materials to the healthcare market. Its business model integrates research and development with large-scale production to ensure the accessibility of essential medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanxi Aoxun Medicine.